Efficacy and safety of biosimilar infliximab in bio-naïve patients with Crohn's disease.
Oike T, Akizue N, Ohta Y, Koseki H, Saito M, Yokoyama Y, Imai Y, Taida T, Okimoto K, Saito K, Ogasawara S, Matsumura T, Nakagawa T, Arai M, Katsuno T, Fukuda Y, Kitsukawa Y, Kato J, Kato N.
Oike T, et al. Among authors: nakagawa t.
Arab J Gastroenterol. 2024 May 6:S1687-1979(24)00036-4. doi: 10.1016/j.ajg.2024.03.006. Online ahead of print.
Arab J Gastroenterol. 2024.
PMID: 38714472